signs of fentanyl overdose

When someone overdoses, the people in the room often lose the most important minutes arguing about whether to call 911. The fear is almost always the same: police will come, someone will be arrested, and a bad night becomes a court case. California has a law written for exactly this moment, and many of the families who call our team after an overdose have never heard of it. This guide explains what the law covers, what it does not, what to do on the call, and how the hours after an emergency room visit can become the start of treatment. If you need to talk to someone about treatment now, call Bodhi Addiction Treatment at (877) 328-1968. If someone is unresponsive or not breathing, call 911 first.

California’s Good Samaritan Overdose Law in One Paragraph

California’s Good Samaritan overdose law, Health and Safety Code section 11376.5, has been in effect since January 1, 2013. It provides that a person who in good faith calls for medical help for someone experiencing a drug-related overdose, and the person who overdosed, generally cannot be charged with being under the influence of a controlled substance or with possessing drugs or paraphernalia for personal use, when the evidence came to light because help was called. It does not protect selling or supplying drugs, does not cancel existing warrants, and does not apply to someone who obstructs the medical or police response. In plain terms: calling 911 for an overdose in California is legally safer than most people believe, and it is far safer than waiting.

What the Law Covers and What It Does Not

The protection is narrower than some people assume and broader than most fear. It is worth knowing both edges before you ever need it.

  • Covered: being under the influence, and possessing a personal-use amount of a controlled substance or paraphernalia, for the caller and for the person who overdosed.
  • Not covered: selling, giving, or exchanging drugs; driving under the influence; outstanding warrants; and unrelated crimes.
  • Uncertain territory: how an overdose call interacts with probation, parole, custody matters, or a professional license depends on the specific situation. If any of those apply, talk to an attorney afterward. Do not let the question delay the call.

California also has a separate law, Civil Code section 1714.22, that addresses liability for people who give naloxone (Narcan) in good faith during a suspected opioid overdose. The practical takeaway is the same: the law is designed to encourage people to act.

Why People Hesitate to Call

In our placement and intervention work with California families, the reasons people give for a delayed call fall into a small number of patterns. Naming them ahead of time makes them easier to override in the moment.

  • Fear of arrest: the most common reason, and the one the Good Samaritan law was written to address.
  • “They’re just sleeping it off”: heavy snoring, gurgling, or slow breathing can look like sleep but may be a sign that breathing is failing.
  • Naloxone already given: people assume the danger is over once the person wakes up, but naloxone can wear off before the opioid does.
  • Shame and secrecy: families who have kept substance use private for years hesitate to bring outsiders into the house.
  • The person refuses: someone who has just been revived may insist they are fine and beg you not to call.

None of these reasons outweighs the risk of a fatal overdose. According to the Centers for Disease Control and Prevention, naloxone and fast emergency response are among the most effective tools for preventing overdose deaths, and both depend on someone acting quickly.

What to Do and Say on the 911 Call

Do this today, before there is an emergency: save the address of the home where your loved one stays as a contact note in your phone, and check whether there is naloxone in the house and where it is kept. Under stress, people forget street addresses and lose time searching drawers.

If an overdose happens:

  1. Call 911 and lead with the facts. Say “Someone is unresponsive and not breathing normally” and give the address. You do not have to open with what drugs were used, but answer the dispatcher’s questions honestly, because it shapes the medical response.
  2. Give naloxone if you have it and opioids could be involved. The National Institute on Drug Abuse explains that naloxone can rapidly reverse an opioid overdose and is not harmful if opioids turn out not to be involved. If there is no response after 2 to 3 minutes, a second dose may be needed.
  3. Support breathing and position. Follow the dispatcher’s instructions. If the person is breathing, place them on their side so they do not choke.
  4. Stay until help arrives. Leaving the scene is the single most common way people lose the protection the law offers and the person loses the help they need.
  5. Do not hide or flush substances in front of responders. Interfering with the response can remove legal protection and keeps medical staff from knowing what they are treating.

Overdoses are not limited to opioids. Alcohol poisoning, sedative combinations, and stimulant toxicity all warrant a 911 call. If the person has been drinking heavily or using benzodiazepines daily, they also face a separate danger in the days after the emergency: withdrawal from alcohol and benzodiazepines can cause seizures and must be medically supervised. Stopping suddenly at home is not safe.

The Hours After the Emergency Room

Here is an inconvenient operational truth from our placement work: the emergency room is designed to stabilize, not to treat addiction, and many people who overdose are discharged within hours. The window between ER discharge and the next use is when families have the most leverage and the least plan. The people who make it into treatment from that window usually have a family member who already did the paperwork.

Three questions to ask before the person leaves the hospital:

  • Can we get a copy of the discharge summary? It lists what was found, what was given, and any lab results. Residential programs use it for medical clearance.
  • Was buprenorphine started, or can it be? Some emergency departments can begin medication for opioid use disorder before discharge.
  • Is there a social worker or substance use navigator on shift? Many California hospitals have one, and they can help coordinate a direct transfer.

At the same time, a family member can start an insurance verification and ask about open beds. Bodhi’s team can often review the hospital paperwork, help confirm benefits, and match your loved one with a vetted partner program the same day, including residential treatment in Northern California for people who need round-the-clock structure after a medical scare. Call (877) 328-1968 while the person is still in the hospital if you can.

What to Tell the Admissions Team After an Overdose

Admissions teams make better placement decisions when they hear the details plainly. Be ready to share:

  • What happened: the date, which substances were involved or suspected, and whether naloxone was used.
  • Daily use pattern: especially daily alcohol, benzodiazepine, or opioid use, since these determine withdrawal risk and whether medically supervised detox is needed first.
  • Medications and diagnoses: prescriptions, mental health conditions, and any history of seizures.
  • Legal context: whether police were present, and any probation or court involvement, so the team can plan documentation.

None of this disqualifies anyone from care. It helps the clinical team decide the right level of care and the safest first 72 hours. The Substance Abuse and Mental Health Services Administration also runs a free, confidential, 24-hour National Helpline at 1-800-662-4357 for treatment referrals in any state.

A Note From Practice

In placement work, I have been on the phone with many parents and partners in the hours after an overdose. The ones who carry the most guilt are rarely the ones who called 911. They are the ones who waited. If you take one thing from this page, let it be this: call first, ask legal questions later, and use the days after the emergency to get your loved one into care while the door is open. If you want help thinking through next steps, our team offers a free treatment consultation, or you can reach us directly at (877) 328-1968.

This article is for educational purposes only and is not legal or medical advice. Laws change and their application depends on specific facts; consult a California attorney about your situation. If someone is unresponsive, not breathing, or having a seizure, call 911 immediately. If you or someone you know is in emotional crisis, call or text 988.

Capitola Addiction Treatment

Most people who call us about residential treatment while holding down a job ask the same question within the first five minutes: Will I still have a job when I get back? Federal and California leave laws get most of the attention, but there is an older, shorter California statute that speaks directly to rehab, and it is one that many employees, and some HR departments, have never heard of.

California Labor Code section 1025 requires every private employer that regularly employs 25 or more people to reasonably accommodate an employee who wants to voluntarily enter and participate in an alcohol or drug rehabilitation program, as long as the accommodation does not impose an undue hardship on the employer. The law does not require paid time off, but it allows the employee to use sick leave they have already earned for treatment, and the companion section 1026 requires the employer to make reasonable efforts to keep the employee’s enrollment private.

That paragraph is the core of this article. The rest explains where the rule helps, where it stops, and what to ask before you leave for treatment. This is general education, not legal advice, and an employment attorney or the California Civil Rights Department can answer questions about your specific situation.

What Labor Code 1025 Actually Says

The statute (California Labor Code section 1025) is short. Its practical pieces break down this way:

  • The 25-employee threshold: The duty applies to private employers that regularly employ 25 or more people, so a small business below that line is not covered by this section.
  • The word “voluntarily”: The protection is written for an employee who wishes to enter treatment, which is why asking before a workplace incident matters so much.
  • Reasonable accommodation: In practice this usually means time away from work to attend a program, and sometimes a schedule change afterward for continuing care.
  • Undue hardship: An employer can decline an accommodation that would impose an undue hardship, which is decided case by case.
  • No paid-leave requirement: The employer does not have to pay you while you are away, but you may use sick leave you are already entitled to.
  • Privacy: Section 1026 requires reasonable efforts to safeguard the fact that you enrolled in a rehabilitation program.
  • The current-use exception: The law does not stop an employer from discharging or refusing to hire someone who, because of current alcohol or drug use, cannot perform the job or cannot do it safely.

How It Fits Next to FMLA, CFRA, and the ADA

Section 1025 is not the only protection, and it is rarely the strongest one on its own. It sits alongside several other laws that may apply at the same time:

  • FMLA: The federal Family and Medical Leave Act covers employers with 50 or more employees and can provide up to 12 weeks of unpaid, job-protected leave for treatment of a serious health condition, which can include substance use disorder treatment provided by a health care provider.
  • CFRA: The California Family Rights Act reaches employers with 5 or more employees and also provides up to 12 weeks of job-protected leave for eligible employees.
  • ADA and FEHA: The federal Americans with Disabilities Act (15 or more employees) and California’s Fair Employment and Housing Act (5 or more employees) can protect people with a history of substance use disorder who are not currently using illegal drugs.

The reason section 1025 still matters is the gap it fills. Someone who has worked at a company for only a few months may not yet meet the 12-month and 1,250-hour eligibility tests that FMLA and CFRA leave require. Section 1025 has no tenure test written into it. For a newer employee at a 25-person or larger company, it can be the clearest legal footing for asking to go to treatment.

Why the Order of Events Matters

In our placement work, the hardest employment situations we see are rarely about which law applies. They are about timing. These are the patterns that most often shrink a person’s options:

  • Asking after an incident: When a request for treatment comes after a positive workplace test, a safety event, or a final warning, the employer may treat it as a disciplinary matter rather than a voluntary request.
  • Resigning first: People sometimes quit out of shame before they ask, which gives up the accommodation, any leave protection, and often the employer health plan that would have helped pay for care.
  • Telling a supervisor but not HR: A hallway conversation with a manager may never reach the people who handle leave and accommodation, so nothing is documented.
  • Waiting for a bed without a plan: When the request and the admission date are not coordinated, people end up absent without approved leave.

None of this means a person who has already had a workplace incident cannot get help. It means the earlier and more formally the request is made, the more protection is usually available.

What to Do This Week: A Five-Step HR Checklist

If you are considering residential treatment and you are employed in California, these steps can be done before you ever speak to a program:

  1. Count your employer. Find out roughly how many people the company regularly employs. Your employee handbook, a recent benefits notice, or HR can tell you. The lines that matter are 5, 15, 25, and 50.
  2. Read the handbook’s leave and EAP sections. Many larger employers have an Employee Assistance Program that offers a confidential first conversation and can sometimes help coordinate leave.
  3. Check your sick leave balance. Section 1025 allows you to use sick leave you have already accrued. Knowing the number helps you plan.
  4. Put the request in writing to HR. A short email is enough. You do not have to name a substance or a diagnosis to start the conversation.
  5. Verify your health coverage before you set a date. Leave status and insurance status are linked. Our team can run a free insurance verification so you know what your plan covers before you commit to an admission date, or call (877) 328-1968.

A request to HR can be as simple as: “I would like to voluntarily enter an alcohol or drug rehabilitation program. I am requesting a reasonable accommodation, including time off, and I would like information about leave options, use of my accrued sick leave, and how this request will be kept confidential.” Then ask three direct questions: Which leave programs am I eligible for? Will my health insurance continue while I am away? Who will know about this request?

Withdrawal Safety Comes Before Paperwork

Employment logistics should never push someone into stopping alcohol or sedatives abruptly to “get a head start” before a leave begins. Alcohol and benzodiazepine withdrawal can cause seizures and other life-threatening complications, and stopping either one should happen under medical supervision. If you drink daily or take benzodiazepines regularly, tell the admissions team exactly how much and how often, and ask whether medically supervised withdrawal management should come first. The National Institute on Drug Abuse describes effective treatment as addressing the whole person, including medical, psychological, social, and vocational needs (NIDA, Principles of Drug Addiction Treatment), and work is part of that picture.

Programs also use structured criteria to decide what level of care fits. The American Society of Addiction Medicine’s framework, The ASAM Criteria, is what many programs and insurers rely on, and the recommended length of stay that comes out of that assessment is often the number HR will ask you for.

How Bodhi Helps With Timing

As a treatment consulting and referral service based in Capitola, our work is matching people to appropriate licensed programs in Northern California and beyond. Because we see the admissions process from the outside, we can help line up the order of events: insurance verification, the level-of-care conversation, a realistic admission date to give HR, and a discharge plan that accounts for the return to work. Learn more about working with a treatment consultant, or call (877) 328-1968 to talk through your situation confidentially, including how to prepare for the HR conversation and the admissions call on the same day.

If you are not ready for that call, the SAMHSA National Helpline at 1-800-662-4357 is free, confidential, and available 24 hours a day for treatment referrals and information (SAMHSA National Helpline). If you are in crisis or thinking about harming yourself, call or text 988, or call 911 in an emergency.

This article is for educational purposes only and is not medical or legal advice. Employment law questions depend on your specific facts and employer; consult an employment attorney or the California Civil Rights Department for guidance. Never stop alcohol or benzodiazepines suddenly without medical supervision. If you are experiencing a medical emergency, call 911.

IV drip stand and medication in a medical detox unit

A common admissions call goes like this. Someone describes months of daily anxiety, poor sleep, and a “supplement” they order online that takes the edge off. They have tried to stop twice. Both times, within a day or so, they could not sleep at all, felt their heart racing, and became so agitated that they started again just to function. The supplement is phenibut. It is not illegal to buy, it rarely comes up in a doctor’s office, and it does not show up on a standard drug test. That combination is exactly why it is easy to underestimate, and why it matters to name it on the first call.

This article explains what phenibut is, why stopping it can be medically risky, what the federal data show, and the specific information to have ready when you contact a residential program.

What Phenibut Is and Why It Is Easy to Miss

Phenibut (beta-phenyl-gamma-aminobutyric acid) was developed in Russia in the 1960s as an anti-anxiety medication. In the United States it is not an FDA-approved drug. According to a CDC report, it is legal to possess and is sold online, often marketed for anxiety, relaxation, and sleep, but the FDA has determined it does not meet the definition of a dietary ingredient and cannot lawfully be listed as an ingredient in dietary supplements. People often buy it as a powder or capsule from overseas or online retailers, with no reliable way to know the actual strength.

Phenibut acts on GABA-B receptors, part of the same calming system targeted by alcohol, benzodiazepines, and baclofen. With daily use, the brain adapts. When the substance is suddenly removed, that adaptation is left unopposed, and the nervous system swings the other way.

What the Federal Poison Center Data Show

The clearest national picture comes from the Centers for Disease Control and Prevention. A CDC analysis of U.S. poison center calls from 2009 through 2019 identified 1,320 phenibut exposures across all 50 states and the District of Columbia; 85% of those calls came from health care facilities, about one in eight cases (12.6%) involved major, life-threatening effects, coma was reported in 6.2% of cases, and three deaths were recorded. The same report notes that phenibut is not detected on routine urine drug screens. The full findings are published in the CDC’s Morbidity and Mortality Weekly Report.

Those figures describe calls to poison centers, not everyone who uses phenibut, and the authors note that the data likely undercount real exposures. But they make one practical point clearly: when phenibut causes harm, it is usually serious enough that someone ends up in an emergency department.

Why Phenibut Withdrawal Needs Medical Supervision

Withdrawal from phenibut can include rebound anxiety, severe insomnia, agitation, tremor, a racing heart, confusion, hallucinations, and in some reported cases acute psychosis. Seizures have been described in case reports. Because phenibut acts on the same calming system as alcohol and benzodiazepines, clinicians generally treat its withdrawal with the same caution. Alcohol and benzodiazepine withdrawal carry a known seizure risk and require medical supervision, and many people who use phenibut also use one or both of those substances.

Here is what drives the risk, in plain terms:

  • Unknown dose: Online products vary in purity and strength, so the amount a person thinks they take may not match what they actually take.
  • Escalation from tolerance: Daily users commonly increase their dose over weeks to get the same effect, which deepens physical dependence.
  • Combination with other sedatives: The CDC data found other substances involved in about 40% of adult cases, and mixing phenibut with alcohol, benzodiazepines, opioids, or gabapentinoids adds to sedation and breathing risk.
  • Invisible on testing: Because routine urine screens do not detect phenibut, a care team can only plan for it if someone tells them.
  • Fast onset: Many people describe withdrawal symptoms beginning within hours to a day of the last dose, which leaves little margin if the plan is to “just stop.”

Do not stop phenibut abruptly on your own, particularly after daily use or if you also drink or take benzodiazepines. A physician-guided plan, which may involve a gradual taper or substitution with a related prescribed medication, is the safer route. If you or someone else has a seizure, severe confusion, or hallucinations during withdrawal, call 911.

What to Tell Admissions: A Checklist to Fill In Today

As a counselor and interventionist, I can say the single most useful thing a caller can do is bring specific numbers. “I take some phenibut” does not let a medical team plan. Before you call, take ten minutes and write down the following:

  1. The product: Brand, form (powder, capsule, tablet), and where it was bought. Take a photo of the label.
  2. The amount: How many grams or capsules per day, and how many times a day you dose.
  3. The timeline: When daily use started and when the amount last increased.
  4. Your last dose: The date and approximate time.
  5. Past attempts to stop: What happened, how quickly symptoms started, and whether there was any seizure, confusion, or hallucination.
  6. Everything else: Alcohol, benzodiazepines, sleep medications, opioids, kratom, gabapentin or pregabalin, and any prescribed psychiatric medications.

Then ask the admissions team two direct questions: “Will a physician review my phenibut history before I arrive?” and “If I need a medically supervised withdrawal, where will that happen and who monitors me overnight?” A clear answer to both is a good sign. If your symptoms suggest you need a higher level of medical care first, a good program will say so and help arrange it.

What the First Week Usually Looks Like

For people whose phenibut withdrawal is managed medically first, the early days of residential treatment often center on sleep, anxiety, and restlessness. Families frequently notice irritability and difficulty sitting through a conversation. That is not a sign treatment is failing. It is the nervous system recalibrating, and it tends to ease as stabilization continues.

Because many people started phenibut to manage anxiety or insomnia, clinical work does not stop at withdrawal. A thorough assessment looks at what the substance was treating. Anxiety disorders, panic, depression, and trauma are common reasons people reach for something calming, and treating those directly is part of reducing the risk of returning to use. The National Institute on Drug Abuse notes that effective treatment addresses the whole person, including co-occurring mental health conditions, not only the substance use. Level-of-care decisions typically follow the ASAM Criteria, which weigh withdrawal risk, medical needs, and mental health together.

Insurance and Practical Steps

Phenibut is not a “recognized” drug on most insurance forms, so documentation matters. Describe it as a GABA-acting sedative with withdrawal risk, list your daily amount and any withdrawal history, and note other sedatives involved. That clinical picture, not the product name, is what supports authorization. You can start a benefits check through our insurance verification page, or call (877) 328-1968 and we will walk through it with you.

Getting Help

If you or someone you love is using phenibut daily and has not been able to stop, call us before attempting to quit alone. We serve people across Northern California and can explain the options at (877) 328-1968. For free, confidential treatment referrals at any hour, the SAMHSA National Helpline is available at 1-800-662-4357. If you are in crisis, call or text 988.

This article is for educational purposes only and is not medical advice. Phenibut products vary in content, and withdrawal can be unpredictable. Never stop phenibut, alcohol, or benzodiazepines abruptly, or leave a withdrawal program, without medical supervision. Consult a qualified medical professional about your specific situation.

Drug and Alcohol Rehab Treatment Serving Olympia

A common admissions call goes like this. Someone is ready for residential treatment, their insurance verification looks clean, and then a detail surfaces: they gave notice at work last Friday, or their hours were cut, or a spouse’s job ended and the family plan goes with it. Nobody planned for coverage to change in the middle of a stay, but it happens often enough that it is worth raising on the very first call. This article explains how continuation coverage works in California, where the real gaps come from, and the specific questions to ask before and during treatment so a paperwork problem does not end a stay early.

Why Coverage Changes During Treatment Are Common

Residential treatment usually comes at a point when substance use has already strained work. Some people resign before admission because they cannot imagine explaining a 30- to 45-day absence. Others are let go during treatment. Others are on a partner’s or parent’s plan that changes for reasons outside their control. Each of these can end employer coverage, often at the end of the month in which the job ends, though the exact date depends on the plan. If you have not yet told your employer anything, protected medical leave may be a better path than resigning; talk with our treatment consultant team before you make that decision.

COBRA in Plain Numbers

Under the federal COBRA law, a person who loses employer health coverage after leaving a job or having hours reduced at a company with 20 or more employees has at least 60 days to elect continuation coverage, which generally lasts up to 18 months and can cost up to 102 percent of the full plan premium. The 60 days run from the later of the date coverage ended or the date the election notice was sent. If you elect within that window and pay the first premium (due within 45 days of electing), coverage is applied back to the date it ended, so claims for treatment received in the gap can still be paid. The U.S. Department of Labor publishes the official rules on its COBRA continuation coverage page.

Timing matters because the paperwork is slow by design. The employer generally has 30 days to notify the plan administrator, and the administrator then has 14 days to send the election notice. A person in week two of residential treatment may not see that letter at all unless someone is checking their mail.

Cal-COBRA, Covered California, and Medi-Cal

California adds options beyond federal COBRA. Cal-COBRA covers people who worked for employers with 2 to 19 employees, and in some situations it can extend continuation coverage to as long as 36 months in total. Covered California treats a loss of job-based coverage as a qualifying event that opens a 60-day special enrollment period, and its annual open enrollment period, which in recent years has run from November 1 through January 31, is open right now. Medi-Cal has no enrollment period at all; if income drops after a job ends, an application can be filed at any time, and residential substance use treatment for Medi-Cal members is arranged through the county.

One rule surprises people: choosing to drop COBRA partway through the year, outside open enrollment, generally does not open a special enrollment period on its own. Compare options before you elect or cancel anything.

Where the Real Gaps Come From

Coverage problems during treatment rarely come from a lack of options. They come from a handful of predictable causes:

  • Unopened mail: the COBRA election notice goes to a home address while the person is in residential care, and the 60-day window passes unnoticed.
  • A new authorization: a new plan, including a Covered California plan, usually requires its own prior authorization or concurrent review, even when the old plan had already approved the stay.
  • Network changes: a marketplace plan may use a different provider network than the employer plan, so a program that was in network last month may not be now.
  • A deductible reset: moving to a new plan typically starts a new deductible and out-of-pocket maximum, even midyear.
  • A hurried resignation: quitting before admission can end coverage days before the stay begins, when protected leave might have kept it in place.

What to Do Today: A Five-Step Coverage Check

If a job change is possible before or during treatment, take these steps now, ideally with a family member who can handle mail and phone calls while you are in care:

  1. Call the member services number on your insurance card and ask: “On what exact date does my coverage end if my employment ends?” Write down the date and the representative’s name.
  2. Ask human resources or the plan administrator whether the employer has 20 or more employees (federal COBRA) or fewer (Cal-COBRA), and where the election notice will be mailed.
  3. Name a mail contact. Give a trusted person permission to open insurance mail and to call you when the COBRA notice arrives.
  4. Tell admissions or billing immediately about any expected change, so the team can plan the authorization for the new coverage instead of discovering it at the next review.
  5. Price the alternatives. Before electing COBRA, compare its monthly cost with a Covered California plan and, if income has dropped, with Medi-Cal eligibility.

Our admissions staff can run a benefits check on your current plan and on any plan you are considering. Start at verify insurance or call (877) 328-1968.

Do Not Stop Treatment Abruptly Over a Coverage Problem

When coverage changes, the instinct is sometimes to leave right away to avoid a bill. That can be medically risky. Alcohol and benzodiazepine withdrawal can cause seizures and must be managed under medical supervision; if withdrawal is not complete, leaving can be dangerous. Ask the clinical team for a safe transition plan, which may mean a step down to a lower level of care rather than a sudden discharge. The ASAM Criteria describe a continuum of care for exactly this reason: treatment intensity can be adjusted rather than simply stopped.

Guidance from the National Institute on Drug Abuse emphasizes that remaining in treatment for an adequate period matters. A short pause to sort out paperwork is far better than an unplanned exit.

What We See From the Admissions Side

From the admissions and case-management side, the most avoidable situation is the person who resigned the week before admission believing it was the honest thing to do, then learned their coverage ended on the last day of that month, sometimes while still in detox. Honesty with an employer and protecting your coverage are not in conflict. You can be truthful about needing medical leave without giving up the job and the insurance attached to it.

The second pattern is families who assume the facility will catch an insurance change automatically. Eligibility is checked, but a plan termination can take weeks to appear in an insurer’s system, and by then days of care may already be in question. The fastest way to protect a stay is for the person or family to tell the team the moment a change is likely. A stay in our residential treatment program in Northern California is planned around authorizations, and that planning works best with advance notice.

Getting Help

If you are weighing treatment and worried about losing coverage, call us before making any job or insurance decision. We can walk through your benefits, the timeline, and the options available in California at (877) 328-1968. For free, confidential treatment referrals at any hour, the SAMHSA National Helpline is available at 1-800-662-4357. If you are in crisis, call or text 988.

This article is for educational purposes only and is not medical, legal, tax, or insurance advice. Coverage rules, deadlines and plan terms vary, and the federal and state rules described here can change. Confirm details with your plan administrator, the U.S. Department of Labor, Covered California, or a qualified professional before making decisions. Never stop alcohol or benzodiazepine use, or leave a withdrawal program, without medical supervision.

Drug and Alcohol Rehab Treatment Serving Kirkland

Tianeptine is sold in the United States in gas stations, smoke shops and online stores, usually as a “supplement” or “focus” product. It is not approved by the U.S. Food and Drug Administration for any medical use, and at the amounts many people end up taking, it acts on the same brain receptors as opioids. When someone calls our admissions line about tianeptine, the conversation often starts the same way: “I didn’t think this counted.” It counts. This guide covers what the drug is, why dependence can build quickly, what residential treatment looks like for it, and exactly what to have ready before you call.

What Tianeptine Is, in One Paragraph

Tianeptine is a drug prescribed as an antidepressant in some countries outside the United States, where the labeled dose is 12.5 mg taken three times a day, or 37.5 mg in total. In the U.S. it has no approved use, yet it is widely sold over the counter under brand names and nicknames such as “gas station heroin.” At doses well above the prescribed amount, tianeptine activates the mu-opioid receptor, the same target as heroin and oxycodone, so regular use can produce opioid-type tolerance, dependence and withdrawal. People entering treatment for tianeptine often report daily amounts far above 37.5 mg, which is why the exact daily total matters so much at admission.

Why Dependence Builds Fast

From the admissions side, tianeptine stories tend to follow a recognizable arc. Someone buys a bottle for energy, mood or focus. It works. Within weeks the effect wears off sooner, so doses creep up and get closer together. Because the drug’s half-life is short, roughly two and a half to three hours in published pharmacology, many people describe dosing several times a day just to feel normal. The mechanisms below explain why that cycle tightens.

  • Opioid receptor activity: At high doses tianeptine stimulates the mu-opioid receptor, which produces euphoria and, over time, physical dependence.
  • Short duration: Effects fade within hours, so the gap between doses shrinks and the first withdrawal signs can show up the same day.
  • Retail availability: Because it sits on a store shelf, people often do not classify it as a drug, and families may not recognize it either.
  • Unreliable labeling: The FDA has warned consumers about tianeptine products and has reported that some contained ingredients not listed on the label, so the real dose is often unknown.

The National Institute on Drug Abuse (NIDA) explains how repeated opioid receptor stimulation leads to tolerance and dependence, and that framework applies here even though tianeptine is not regulated the same way as prescription opioids in most of the country.

What Withdrawal Looks Like in Week One

Tianeptine withdrawal generally resembles opioid withdrawal. People describe intense restlessness, anxiety, sweating, yawning, runny nose, stomach cramps, diarrhea, nausea, muscle aches, chills and insomnia, along with strong cravings. Mood can drop sharply. Families often notice irritability and pacing before anything else. Because the drug wears off quickly, symptoms may start within hours of the last dose rather than the next day.

Withdrawal from tianeptine alone is generally not the seizure risk that alcohol or benzodiazepine withdrawal is, but it can be severe, and it is very hard to get through at home without returning to use. Many people who reach us also drink or use sedatives to blunt the symptoms. Alcohol and benzodiazepine withdrawal carry a real risk of seizures and require medical supervision. If either is part of the picture, do not stop on your own; tell admissions so a medically managed plan can be built.

The Drug Test Problem

Standard urine drug panels used in clinics and workplaces do not detect tianeptine. A clean test does not rule it out, and a care team will not know it is involved unless you say so. That is the single most important operational fact for anyone seeking treatment: the information has to come from you or your family. Specialized lab testing exists but is not routine, and results can take days. In practice, the history you give on the first call shapes the withdrawal plan.

What Residential Treatment Looks Like for Tianeptine

There is no FDA-approved medication specifically for tianeptine use disorder. Care teams generally manage withdrawal with the same principles used for opioid withdrawal: symptom-targeted medications, close monitoring of vital signs, hydration, sleep support and, where a physician judges it appropriate, medications used in opioid use disorder care. Decisions are individualized and depend on your amounts, other substances and medical history. The American Society of Addiction Medicine (ASAM) publishes the clinical guidance that shapes how level of care and withdrawal management are matched to each person.

After stabilization, the work in residential treatment shifts to the reasons the product was appealing in the first place. For many people that is untreated depression, anxiety, attention problems or chronic pain. Treating those directly, with legitimate care, is a large part of what keeps someone from going back to the shelf.

What to Tell Admissions: A Checklist You Can Use Today

Before you call, take five minutes and write down the following. This turns a vague conversation into a usable clinical history:

  1. The product name and form. Brand, capsule or powder, and a photo of the label. Bring the packaging if you have it.
  2. Your daily total. Count bottles or capsules used in a typical week and divide by seven. Write it in milligrams or grams. Compare it to the 37.5 mg daily prescribed dose so you can see the gap clearly.
  3. How often you dose. Every few hours? Overnight? This helps predict how quickly withdrawal will start.
  4. Time of your last dose. Note it the morning you travel.
  5. Everything else. Alcohol, benzodiazepines, kratom, opioids, stimulants, cannabis and all prescriptions. Alcohol and benzodiazepines change the safety plan.
  6. Past withdrawal attempts. What happened, and how long you lasted.

Then call our admissions team at (877) 328-1968. We can also verify your insurance benefits during the same call, so you know your coverage before a bed date is set.

Overdose Safety While You Wait

Tianeptine overdose can cause heavy sedation and slowed breathing, especially when combined with alcohol, benzodiazepines or other opioids. Published case reports describe naloxone reversing tianeptine overdoses, so keeping naloxone in the home is a reasonable step. The Centers for Disease Control and Prevention (CDC) offers guidance on recognizing an overdose and using naloxone. If someone is unresponsive or breathing slowly, call 911 immediately.

For Families

Families often find empty bottles and assume a vitamin. Look for products marketed for mood, focus or energy with “tianeptine” on the ingredient panel, frequent trips to the same store, and a pattern of restlessness or sickness that eases right after a trip. You can call admissions yourself to ask questions. The SAMHSA National Helpline at 1-800-662-4357 is free, confidential and available around the clock for referrals. If someone is in crisis or having thoughts of suicide, call or text 988.

A Note From Practice

This article is written by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i, drawing on years of admissions and placement conversations in Northern California. The pattern worth repeating: the people whose first days go most smoothly are usually the ones who arrive with an honest, specific number. “A lot” cannot be planned around. “About this many capsules a day, every three hours, last dose at 7 a.m.” can. If you are not sure whether your use calls for residential care, call (877) 328-1968 and ask. You do not need to have decided anything to make that call.

Educational disclaimer: This article is for general educational purposes only and is not medical advice, diagnosis or treatment. Tianeptine regulation varies by state and changes over time. Do not stop alcohol, benzodiazepines or any medication without medical supervision. If you or someone you love is in immediate danger, call 911. For crisis support, call or text 988.

Outpatient Rehab Near Santa Cruz

Nitrous oxide is the substance people most often leave off the admissions call. It is sold legally in smoke shops and online as whipped-cream chargers or large flavored tanks, so many people do not think of it as a drug at all. By the time someone reaches residential treatment for alcohol, stimulants or opioids, a daily nitrous habit may have been running quietly alongside it for months, and the first clue is often numbness in the feet that nobody connected to the canisters in the car.

This guide explains what nitrous oxide does to vitamin B12, why that matters for the nervous system, how a residential team typically handles it in the first days, and exactly what to tell admissions so the right labs and the right medical review happen on day one.

How Nitrous Oxide Use Shows Up at Admission

Nitrous oxide (“whippets,” “nangs,” “galaxy gas”) is inhaled for a short, dissociative high that fades within minutes. Because each hit is so brief, people who use it heavily tend to use it in long sessions, repeatedly, and the totals add up quickly. The National Institute on Drug Abuse groups it with other inhalants, and the risks it describes include oxygen deprivation, accidents while intoxicated, and nerve damage with heavy use.

In admissions work, the pattern we see most often is not nitrous on its own. It is nitrous alongside alcohol, cannabis or stimulants, reported only when someone asks directly. People rarely volunteer it, partly because it was bought at a store and partly because the high is so short that it does not feel like the “main” problem. That is why it belongs on the intake checklist by name.

Why Nitrous Oxide Damages Nerves: The B12 Mechanism

Nitrous oxide does not just cause a temporary high. With repeated exposure, it switches off vitamin B12 inside the body, and B12 is essential for maintaining the protective coating around nerves in the spinal cord and limbs. The damage can build up even in someone who eats well and has never had a B12 problem before.

B12 inactivation: Nitrous oxide chemically oxidizes the cobalt atom at the center of vitamin B12, leaving the vitamin present in the blood but unable to do its job.

Myelin breakdown: Without working B12, the body cannot properly maintain myelin, the insulation around nerve fibers, so signals in the spinal cord and peripheral nerves begin to fail.

Misleading blood tests: Because inactivated B12 can still register on a standard serum test, a “normal” B12 result can sit alongside a real functional deficiency, so clinicians often add methylmalonic acid and homocysteine levels, which tend to rise when B12 is not working.

Dose and duration: Risk generally rises with how much is used and for how long, which is why the quantity and timeline you report matter more than the label “nitrous use.”

Warning Signs That Need Medical Attention

The symptoms of nitrous-related nerve damage usually start in the hands and feet and can be mistaken for anxiety, a pinched nerve or “just being run down.” Tell a medical provider promptly if any of these are present:

  • Numbness, tingling or “pins and needles” in the feet, legs or hands
  • Unsteady walking, especially in the dark or with eyes closed
  • Weakness in the legs, frequent tripping or difficulty on stairs
  • Changes in bladder or bowel control
  • Memory problems, low mood or confusion that is new or worsening

Sudden collapse, trouble breathing, chest pain or loss of consciousness during or after use is an emergency. Call 911.

What to Tell Admissions: The Nitrous Oxide Checklist

When someone calls about residential care and nitrous oxide is part of the picture, the most useful thing to bring is numbers, not adjectives. A standard whipped-cream charger contains 8 grams of nitrous oxide, and large flavored tanks hold many times that amount, so “how many chargers or tanks, of what size, per day” gives the clinical team a real picture of exposure that “a lot” does not. Before the admissions call, write down the container size in grams, the number used on a typical day, the date of last use, and whether any numbness or balance changes have started.

Bring this list to the call, or have a family member fill it in:

  1. Product and size: Small chargers or large tanks? Write down the grams printed on the container.
  2. Quantity: How many chargers, or how much of a tank, on a typical day and on the heaviest days.
  3. Duration: Roughly when daily or near-daily use started.
  4. Last use: Date and approximate time.
  5. Other substances: Especially alcohol, benzodiazepines, opioids or stimulants, and the daily amount of each.
  6. Symptoms now: Any numbness, tingling, falls, weakness or bladder changes, and when they began.
  7. Prior workup: Any recent ER visit, neurology referral or B12 test, and whether you have the results.

One question worth asking at the next medical appointment, or during the admissions call: “If my B12 comes back normal, will you also check methylmalonic acid and homocysteine?” That single question can prevent a false reassurance.

What the First Week of Residential Treatment Usually Looks Like

Nitrous oxide itself does not usually produce a dangerous physical withdrawal syndrome the way alcohol does. People commonly describe strong cravings, irritability, restlessness and poor sleep in the first days, which the clinical team addresses with structure, counseling and close observation. The medical priority is the nervous system: a baseline check of sensation, balance and gait, lab work, and a physician’s decision about B12 replacement, which is often started by injection when nerve symptoms are present.

Recovery of nerve function after stopping, when it happens, generally takes weeks to months, and some people are left with lasting symptoms. Nobody can promise a full return to baseline, which is the strongest practical argument for stopping early rather than waiting for symptoms to “settle.”

The bigger safety question in week one is almost always what else was being used. Withdrawal from alcohol or benzodiazepines can cause seizures and can be life-threatening; it requires medical supervision and should never be attempted alone. If nitrous was used to take the edge off a hangover or a benzodiazepine taper, that detail changes how the medical team plans the first 72 hours, so say it out loud on the call. You can read more about how this is structured on our residential treatment page.

Treating the Use, Not Just the Vitamin

B12 replacement treats the deficiency; it does not treat the pattern of use. Repeated, compulsive inhalant use that continues despite harm is a substance use disorder, and the core tools are the same ones used across addiction treatment: individual therapy, cognitive behavioral approaches, group work, family involvement and a discharge plan that names specific triggers. SAMHSA’s National Helpline and treatment resources emphasize matching care to the whole person, including co-occurring mental health conditions, which are common in people who use dissociative substances to switch off.

Relapse-prevention work for nitrous is unusually concrete. The product is inexpensive, easy to buy and often delivered to the door, so the discharge plan frequently includes removing payment apps or delivery accounts linked to past purchases and agreeing with family on what to do if canisters show up in the trash or the car.

For Families: What You May Notice

Families often find the evidence before they find the explanation: small silver canisters, balloons, large colored tanks, or a sweet chemical smell in a car. They may also notice a loved one walking differently or complaining that their feet feel “asleep” all the time. If you see both the canisters and the numbness, treat it as a medical issue first. Encourage a doctor’s visit, mention nitrous oxide to the clinician by name, and keep a dated note of what you have found.

Getting Help in Northern California

If nitrous oxide is part of the picture alongside alcohol, stimulants or other substances, call (877) 328-1968. Our admissions team will ask the questions above, explain how medical review works in the first days, and help you verify your insurance benefits before you arrive. If you are reading this for someone you love and are not sure where to start, the same number works for families.

Clinical oversight of this article is provided by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i. Questions about whether residential care is the right fit are welcome at (877) 328-1968, and SAMHSA’s National Helpline at 1-800-662-4357 offers free, confidential treatment referral information 24 hours a day.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Do not start, stop or change any medication or supplement without guidance from a qualified provider. Withdrawal from alcohol or benzodiazepines can be life-threatening and requires medical supervision. If you or someone you love is in crisis, call or text 988, or call 911 in an emergency.

Morning light filtering through tall coastal redwoods, evoking the calm of a holistic residential setting

Every week, some of the calls our admissions team takes come from outside California: a parent in Arizona, a spouse in Texas, an adult child in Oregon arranging care for a father in Nevada. Traveling for residential treatment can be a sound choice. Distance from familiar people, places and routines helps some people settle into the work. But the logistics of getting from home to a residential treatment program in Northern California carry real clinical and financial risks, and most of them are decided in the days before anyone gets on a plane.

This guide walks through the parts that tend to go wrong: insurance that does not travel, withdrawal that starts mid-trip, medications at airport security, and the information admissions needs before you book anything. If you would rather talk it through, call (877) 328-1968.

The Single Most Important Rule: Do Not Stop Drinking to Travel

For a person who drinks heavily every day, alcohol withdrawal symptoms usually begin within 6 to 24 hours of the last drink, and the period of highest seizure risk generally falls between 24 and 48 hours, so a person traveling to residential treatment from another state should not stop drinking on their own to “arrive sober.” The trip should be planned with admissions so that withdrawal begins under medical supervision, not on a plane or a highway.

That paragraph is the one we would most like families to remember. The same caution applies to benzodiazepines such as alprazolam (Xanax), clonazepam (Klonopin) and lorazepam (Ativan): stopping abruptly can cause seizures, and tapering requires medical supervision. Withdrawal from alcohol and benzodiazepines is not something to push through on a travel day.

From years of intake calls, I can tell you the pattern we see most often is well-intentioned. Someone decides they want to show up “clean” out of respect for the program, stops drinking the night before a morning flight, and is shaking, sweating and frightened by the time they reach the connecting gate. Others drink heavily on the plane because they believe it is their last chance. Neither plan is safe, and both are avoidable with one honest conversation before booking. In some situations, the safest plan is a medically managed detox near home first, then travel once stable. In others, it is arriving within a window the medical team agrees on. That decision belongs to clinicians, not to the person in withdrawal.

If someone is confused, seeing or hearing things that are not there, has a seizure, or cannot stay awake, call 911. Withdrawal emergencies are medical emergencies.

Why Out-of-State Logistics Go Wrong

The problems families run into tend to fall into a few predictable categories:

  • Insurance network rules: Many plans cover out-of-state, out-of-network residential care at a lower rate or not at all, and families often learn this after admission.
  • Withdrawal timing: The travel day gets scheduled around flights and work calendars instead of around the person’s last drink or last dose.
  • Medication gaps: Prescriptions are packed in checked luggage, run out before arrival, or are left at home entirely.
  • Missing medical history: Records from home providers do not arrive, so the clinical team starts with an incomplete picture.
  • Unplanned discharge: Nobody has thought about how the person gets home, or what aftercare looks like hundreds of miles away.

Insurance: What to Check Before You Book

Insurance is usually the deciding factor for out-of-state treatment, and plan type matters more than almost anything else.

PPO plans frequently include out-of-network benefits, though deductibles, coinsurance and out-of-pocket maximums are often higher than for in-network care. HMO and EPO plans generally do not pay for non-emergency out-of-network care unless the plan grants an exception or authorization. State Medicaid programs generally do not cover non-emergency treatment in another state, so a person with Medicaid from outside California should ask their own state’s program or managed care plan what is covered before planning to travel.

Federal mental health parity law requires most plans to cover substance use treatment on terms no more restrictive than comparable medical care, but parity does not erase network rules. The fastest way to get a real answer is to have the program check the policy directly. You can start with our insurance verification form, and ask these specific questions:

  • Does the plan have out-of-network benefits for residential substance use treatment?
  • Is prior authorization required, and who requests it?
  • What is the out-of-network deductible and out-of-pocket maximum, and how much has already been met this year?
  • How are continued-stay reviews handled once the person is admitted?

Medications and Airport Security

Bring every current medication, in its original pharmacy-labeled container, in your carry-on bag. Checked luggage gets lost, and a missed dose of some medications, including buprenorphine, methadone, antiseizure medications and certain psychiatric medications, can cause real harm.

Under the Transportation Security Administration’s 3-1-1 rule, liquids in carry-on bags are normally limited to containers of 3.4 ounces (100 milliliters). Medically necessary liquids are an exception and are allowed in larger, reasonable quantities, but they should be declared to the officer at the checkpoint. Pills do not fall under the liquid limit.

Two cautions from clinical practice. First, do not take an extra sedative, sleep aid or “something to calm the nerves” for the flight without talking to the prescriber and admissions team; combining sedatives with alcohol or opioids can slow breathing. Second, if someone uses opioids, carry naloxone. The Substance Abuse and Mental Health Services Administration (SAMHSA) identifies naloxone as a key tool for reversing opioid overdose.

What to Tell Admissions Before Anyone Books Travel

Here is something you can do today. Before buying a ticket, write down the answers below and read them to the admissions coordinator on the phone. It takes about ten minutes, and in our experience it is the clearest difference between a smooth arrival and a difficult one.

  1. Last use: What substances, how much, and the date and time of the last drink or dose.
  2. Daily pattern: How much alcohol or how many pills on a typical day, and for how long.
  3. Withdrawal history: Any past seizures, delirium tremens, hospitalizations or prior detox stays.
  4. Medications: Every prescription, dose and prescriber, including medications for opioid use disorder.
  5. Medical conditions: Heart, liver, lung or seizure conditions, pregnancy, and recent ER visits.
  6. Insurance card: Front and back, and the plan type (PPO, HMO, EPO or Medicaid).
  7. Travel plan: Departure city, total travel time, layovers, and who will travel with the person.

Then ask one question directly: “Given this history, when should the last drink or dose happen relative to the flight, and does this person need detox before traveling?” If the answer is that detox should come first, ask whether that can be arranged close to home or whether medically managed alcohol detox on arrival makes more sense.

Who Should Travel With the Person

Whenever possible, someone sober and calm should travel with the person entering treatment, from the front door to the admissions desk. That companion’s job is simple: keep the itinerary moving, hold the medications and documents, and call the program if anything changes. Families often ask whether it is better to drive or fly. There is no universal answer. Shorter total travel time is usually better, and a long solo drive by someone who may enter withdrawal is not a safe option.

Ask the program whether it can help with arrival logistics, such as coordinating a pickup from the airport, so the person is never left waiting alone with easy access to alcohol.

Planning for the Trip Home

Out-of-state treatment works best when aftercare is planned for the place the person actually lives. Before discharge, ask the clinical team to help arrange a first outpatient appointment, a prescriber for any ongoing medications, and recovery support near home. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) Alcohol Treatment Navigator can help families find follow-up care, and SAMHSA’s National Helpline at 1-800-662-4357 offers free, confidential referral information in every state.

The American Society of Addiction Medicine (ASAM) describes addiction treatment as a continuum of care rather than a single stay, and that matters even more when residential care is far from home. The gap between discharge and the first local appointment is a vulnerable time, especially after opioid use, when tolerance may be lower than before treatment.

Getting Started

Traveling for treatment is a big decision, and the details matter. If you are arranging care for yourself or someone you love from outside California, call (877) 328-1968 before booking travel. We will walk through insurance, withdrawal safety and arrival timing so the trip itself is not the riskiest part of getting help.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Insurance coverage varies by plan; confirm benefits with your insurer. Withdrawal from alcohol or benzodiazepines can be life-threatening and requires medical supervision. If you or someone you love is in crisis, call or text 988, or call 911 in an emergency.

Addiction Treatment — Bodhi Addiction Treatment & Wellness

Families often describe it the same way on the first call: “It’s only tramadol. The doctor prescribed it.” That framing is understandable, and it is also where admissions mistakes start. Tramadol is an opioid with a second, non-opioid mechanism layered on top, and both matter when someone stops taking it. This guide walks through what tramadol dependence looks like in residential treatment, why withdrawal needs medical supervision, and the specific details to have ready before you call admissions.

Tramadol at a glance: the numbers that shape an admission

Tramadol has been a federally controlled Schedule IV substance since August 18, 2014, and its prescribing label caps immediate-release tablets at 400 mg per day. For a person entering residential treatment, the dose actually taken in the last 30 days, counted in milligrams rather than pills, is the single most useful fact the admissions team can receive, because both seizure risk and withdrawal planning scale with it. Tramadol also comes in extended-release forms and in a combination tablet with acetaminophen, and each version changes the medical picture differently.

Many people who become dependent on tramadol did not set out to misuse anything. They started with a legitimate prescription for back pain, a dental procedure or arthritis, and the dose crept up over months. The National Institute on Drug Abuse (NIDA) describes how tolerance and physical dependence can develop with prescription opioids taken as directed, and how that is different from, but can lead to, opioid use disorder. A clinical assessment, not the label on the bottle, decides which one is present.

Why tramadol needs a medical plan, not just willpower

Tramadol behaves differently from most other opioids. In practice, these are the mechanisms that drive the medical decisions during a residential stay:

  • Opioid activity: The liver converts tramadol into a metabolite that acts on opioid receptors, so regular use produces tolerance and opioid-type withdrawal when it stops.
  • Serotonin and norepinephrine effects: Tramadol also slows the reuptake of serotonin and norepinephrine, which is why stopping it can bring mood and anxiety symptoms that look more like antidepressant discontinuation than typical opioid withdrawal.
  • Seizure threshold: The FDA label warns that seizures have been reported with tramadol even within the recommended dose range, and the risk rises at higher doses and when it is combined with certain antidepressants or other medications.
  • Serotonin syndrome risk: Combining tramadol with SSRIs, SNRIs, MAO inhibitors or some migraine medications can cause serotonin syndrome, so the full medication list has to be reviewed before anything is added or changed.
  • Genetic metabolism differences: How fast a person’s liver enzymes convert tramadol varies, which is one reason two people on the same dose can have very different experiences in withdrawal.

Alcohol and benzodiazepines change the risk again. If tramadol is used alongside either one, withdrawal from those substances carries its own seizure risk, and medical supervision is required. Never stop alcohol or benzodiazepines abruptly without a physician’s plan.

What the first week typically looks like

Most people experience a recognizable opioid withdrawal pattern: restlessness, aching muscles and joints, yawning, runny nose, sweating, stomach cramps, diarrhea and poor sleep. Symptoms from immediate-release tramadol commonly begin within a day of the last dose, while extended-release products can shift that timeline later.

A smaller group of people report symptoms that are less typical for opioids: intense anxiety or panic, tingling or numbness in the hands and feet, confusion, and occasionally unusual perceptions. Because these can be frightening and can be mistaken for a new psychiatric problem, it helps when the clinical team knows to expect them. Families visiting during week one often notice that the person seems more anxious than sick, and that is consistent with tramadol’s dual action.

In medically supervised residential care, the plan is individualized. Some people complete a gradual taper. Others are better served by starting a medication for opioid use disorder, such as buprenorphine or methadone, which the American Society of Addiction Medicine (ASAM) national practice guideline supports as effective treatment for opioid use disorder. Comfort medications for sleep, nausea and muscle aches are usually part of the plan, with careful attention to anything that could interact with tramadol’s serotonin effects.

What I see go wrong on admissions calls

From years of placing people in residential treatment, the most common miss with tramadol is not dishonesty. It is under-description. A caller says “a few pills a day,” the intake team hears a modest prescription, and the facility plans for a low-acuity admission. Then it turns out the person was taking far more than prescribed, was also on an antidepressant, and had a seizure once that nobody connected to the medication. Each of those three facts changes the medical plan, and sometimes changes which program is the right fit.

The second inconvenient truth is that tramadol is often the medication a person was switched to because it seemed safer than other opioids. That history means people and families tend to downplay it, and it is one reason we ask about tramadol specifically rather than relying on a general “any opioids?” question.

What to tell admissions: a checklist you can do today

Before you call, take ten minutes and write down the answers to these questions. If you are calling for a loved one, gather what you can and say plainly what you do not know.

  1. Which product: immediate-release, extended-release, or the tramadol and acetaminophen combination tablet. Read the bottle label.
  2. Daily dose in milligrams: count tablets used per day over the last 30 days and multiply by the strength printed on the label. Note the highest single day, not just the average.
  3. Last dose: the date and time of the most recent tablet.
  4. Seizure history: any seizure ever, with or without a known cause, plus any head injury or epilepsy diagnosis.
  5. Every other medication: especially antidepressants, migraine medications, other opioids, sleep medications and benzodiazepines.
  6. Alcohol use: a realistic count of drinks per day. Combined alcohol and tramadol use changes withdrawal safety.
  7. Acetaminophen total: if the combination tablet was used, add up daily acetaminophen from all sources, since high totals raise concerns about liver health.

Then ask the admissions team one direct question: “Who will supervise the taper or medication start, and how often will vital signs be checked in the first 72 hours?” A clear answer is a good sign. You can reach our team at (877) 328-1968 to walk through this list together, and you can also verify insurance benefits before the call so cost questions do not delay a safe start.

How residential treatment builds on detox

Withdrawal management is the beginning, not the treatment itself. In residential treatment, the work shifts to the reasons the dose climbed: untreated pain, sleep problems, anxiety, depression, or stress that the medication was quietly managing. A good program coordinates with a pain specialist where needed, so that leaving tramadol does not mean leaving pain untreated. Non-opioid pain approaches, physical therapy and behavioral therapies are typically part of that plan.

Discharge planning should include whether to continue a medication for opioid use disorder, naloxone for the home, and a follow-up appointment with a prescriber who knows the full history. The SAMHSA National Helpline at 1-800-662-4357 offers free, confidential referral information around the clock, and the CDC overdose prevention resources explain how lost tolerance after a period of abstinence raises overdose risk if use resumes.

Safety first

If someone taking tramadol has a seizure, becomes very confused, has a high fever with muscle rigidity or twitching, or has slow or shallow breathing, call 911. Naloxone can reverse opioid effects and should be given if an overdose is suspected, but it is not a seizure treatment, so emergency care is still needed. If you or someone you love is in emotional crisis, call or text 988.

If tramadol has become harder to stop than expected, you do not have to sort out the medical plan alone. Call (877) 328-1968 and we will help you understand the options, the level of care that fits, and what to bring on admission day. You can read more about our clinical background on Jonathan Beazley’s profile.

This article is for educational purposes only and is not medical advice. It does not replace an evaluation by a licensed physician or addiction specialist. Do not stop or change any prescribed medication, including tramadol, alcohol or benzodiazepines, without medical supervision.

Bodhi Addiction — Bodhi Addiction Treatment & Wellness

Most people who reach out to us about zolpidem (sold as Ambien and Ambien CR) did not set out to misuse anything. A doctor prescribed a sleep medication, it worked, and over months or years one tablet became two, then a second dose at 3 a.m., then a glass of wine to help it along. By the time a spouse or adult child calls, the question is rarely “is this a problem?” It is “how do we stop safely, and what does admission actually involve?” This guide answers the second question.

Zolpidem and Residential Treatment: The Key Facts

Zolpidem is a Schedule IV prescription sleep medication that acts on the same GABA-A receptor system as benzodiazepines and alcohol. In April 2019 the U.S. Food and Drug Administration added a boxed warning, its strongest safety label, to zolpidem, zaleplon and eszopiclone after reports of serious injuries and deaths linked to complex sleep behaviors such as sleepwalking and sleep-driving. Because zolpidem dependence develops through the same brain system as alcohol and benzodiazepine dependence, a person who has been taking more than prescribed, taking it during the day, or combining it with alcohol should not stop abruptly on their own. The safer route is a medically supervised taper, which a residential program with medical staff can provide.

A second date matters for families. In January 2013 the FDA lowered the recommended starting dose of immediate-release zolpidem for women from 10 mg to 5 mg (and of extended-release from 12.5 mg to 6.25 mg) because blood levels high enough to impair driving were found the next morning. If someone has been taking several times that amount nightly, next-morning impairment is a safety issue now, not only a treatment issue later.

What Zolpidem Dependence Looks Like Before Admission

From the admissions side, the picture is consistent. People describe lying awake for an hour or more if they skip a dose, then taking extra “just to get some sleep.” Families describe conversations the person does not remember the next day, late-night online orders, food eaten with no memory of it, or a car moved in the night. Some people start taking a half tablet in the afternoon because it takes the edge off anxiety. Prescriptions run out before the refill date, and a second prescriber, or a supply from a friend, fills the gap.

None of this means a person is weak or careless. Sedative-hypnotic use disorder is a recognized medical condition, and the National Institute on Drug Abuse (NIDA) lists prescription sedatives among the medications that can lead to dependence and addiction when they are misused.

Why Use Escalates: The Five Mechanisms We See

  • Tolerance: The same dose produces less sleep over weeks to months, so the dose creeps up to get the original effect.
  • Rebound insomnia: Skipping a night produces worse sleep than before the medication was started, which convinces the person they cannot sleep without it.
  • Daytime use: Zolpidem’s calming effect gets used for anxiety or stress during the day, which turns a sleep aid into an all-day sedative.
  • Alcohol stacking: Alcohol and zolpidem both depress breathing and coordination, and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) flags sleep medications among the dangerous alcohol-medication combinations.
  • Amnesia hides the amount: Because zolpidem can cause memory gaps, the person may sincerely not know how many tablets they took on a given night.

Why Zolpidem Is Not Stopped Cold

When the brain has adapted to a GABA-A medication, removing it suddenly can produce rebound insomnia, anxiety, agitation, tremor and, particularly after high doses, seizures. The risk depends on the dose, how long it has been taken, and what else is in the picture. Alcohol and benzodiazepines matter most here: alcohol and benzodiazepine withdrawal carry seizure risk, and anyone dependent on either, alone or alongside zolpidem, requires medical supervision to stop. The same caution applies to stopping a high daily dose of zolpidem itself.

A taper is planned by a prescriber based on the actual dose being taken, not the dose on the label. In some cases the medical team converts to a longer-acting medication and reduces that gradually; in others zolpidem itself is reduced step by step. The schedule is individual, and it is adjusted if symptoms appear. If you are reading this before admission, do not stop or sharply cut your dose on your own. Keep taking it as you have been, unless your prescriber has given you different instructions, and tell admissions exactly when you took the last dose.

What Happens in Week One of Residential Treatment

The first days are about safety and sleep, in that order. Expect a medical and psychiatric assessment on arrival, a review of every bottle you bring, and regular vital-sign and symptom checks while the taper begins. The first several nights are usually the hardest; many people sleep in short stretches and wake early. That is expected, and staff are awake overnight.

Programs place people by clinical need using frameworks such as the American Society of Addiction Medicine (ASAM) clinical guidelines, so the level of medical monitoring during a sedative taper is matched to the risk. You can read more about how our residential treatment program structures the first week and the medical support around it.

Beyond the taper, week one also starts the work that keeps the change from reversing: screening for depression, anxiety and trauma that the medication may have been covering, and counseling that looks at what the nightly ritual was doing for the person.

What to Tell Admissions: A 10-Minute Checklist

In my years doing intake calls and interventions, the most common gap I hear is the difference between the dose on the bottle and the dose actually being taken. Admissions can only plan a safe taper around the real number. Before you call (877) 328-1968, take ten minutes and write down the following:

  1. The prescribed dose and the name of every prescriber, including telehealth and urgent care.
  2. The dose actually taken on a typical night over the last two weeks, including middle-of-the-night doses and any daytime use.
  3. The last fill date and quantity from the label. Count what is left. Fill date, quantity and remaining count together show the true daily rate better than memory does.
  4. Every other sedative: alcohol (in standard drinks), benzodiazepines, gabapentin or pregabalin, opioids, muscle relaxants, cannabis and over-the-counter sleep aids.
  5. Any seizure history, any withdrawal you have had before, and any falls, sleep-driving or blackout events.
  6. The time of your last dose, written down on admission day.

Bring all medication bottles, in their original labeled containers, on admission day. If you are not sure what your plan will cover, our team can verify your insurance benefits before you commit to a date.

Treating the Insomnia Underneath

Stopping zolpidem does not end the sleep problem it was prescribed for, and pretending otherwise sets people up to restart. Sleep usually improves gradually over the weeks after a taper. During treatment, care focuses on approaches that do not depend on a sedative: consistent wake times, daylight and movement, limiting caffeine, and cognitive behavioral therapy for insomnia (CBT-I), a structured, non-drug treatment. Anxiety, depression and trauma symptoms that were being quieted at night are treated directly, and the discharge plan should name who will manage sleep afterward.

Getting Started

If you or someone you love depends on zolpidem, the next step is a conversation, not a decision to stop tonight. Call (877) 328-1968 to talk through the dose, the timeline and what admission involves. For free, confidential treatment referral 24 hours a day, you can also reach SAMHSA’s National Helpline at 1-800-662-4357. If someone is hard to wake, breathing slowly, or has had a seizure, call 911. If you are in emotional crisis, call or text 988.

Written by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i, drawing on his work in admissions, intervention and residential addiction treatment in Northern California.

Educational disclaimer: This article is for general educational purposes only and is not medical advice. It does not replace an evaluation by a licensed medical professional. Do not stop, reduce or change any prescribed medication without guidance from your prescriber. Withdrawal from sedatives, alcohol or benzodiazepines can be dangerous and requires medical supervision. If you are experiencing a medical emergency, call 911.

Drug and Alcohol Rehab Treatment Serving Kirkland

Gabapentin (brand name Neurontin) and pregabalin (Lyrica) are prescribed every day for nerve pain, seizures, and sometimes off-label for anxiety, sleep, or alcohol withdrawal. Because they arrive from a pharmacy with a doctor’s name on the label, many people don’t think of them as part of their substance use at all. In residential admissions, that is exactly why they get missed. This guide covers how these medications are handled when someone enters residential treatment, why stopping them suddenly is not safe, and what to have ready before you call admissions.

The Short Answer: Gabapentin Should Not Be Stopped Abruptly

Gabapentin should never be stopped “cold turkey” on admission to residential treatment. The FDA-approved prescribing information for Neurontin directs that when the medication is reduced or discontinued, it be done gradually over a minimum of one week, and it warns that antiepileptic drugs should not be stopped abruptly because of the possibility of increased seizure frequency. People who have been taking more than prescribed, or combining gabapentin with alcohol, benzodiazepines, or opioids, generally need a slower, medically supervised taper than that one-week floor, planned by a prescriber who knows their full history.

Why Gabapentin and Pregabalin Misuse Is Often Missed

From the admissions side, the pattern is consistent: a person describes their alcohol or opioid use in detail, then mentions gabapentin almost as an afterthought, or not at all. Several things drive that:

  • It is prescribed, not purchased: A pharmacy label makes the medication feel like healthcare rather than substance use, even when the daily amount has drifted well past the prescription.
  • Gabapentin is not federally controlled: Pregabalin is a Schedule V controlled substance under federal law, but gabapentin is not federally scheduled, so it can fall outside the questions people expect to be asked.
  • It is used to manage other substances: Some people use gabapentin to soften opioid withdrawal or to blunt alcohol cravings, so they see it as part of the solution rather than part of the problem.
  • It amplifies other depressants: Taken with opioids or alcohol, gabapentin can intensify sedation, which is part of why some people take extra and part of why the combination is dangerous.

None of this means a gabapentin prescription is a problem in itself. Many people take it exactly as directed and benefit. The clinical question in admissions is simply whether the amount, the source, and the combination with other substances match the prescription.

The Breathing Risk When Gabapentinoids Are Combined With Opioids

In December 2019, the U.S. Food and Drug Administration added warnings that gabapentin and pregabalin can cause serious breathing difficulties in people with respiratory risk factors, including people who also use opioids or other central nervous system depressants, older adults, and people with lung conditions such as COPD. This matters for residential admissions because many people entering treatment for opioid use disorder are also taking gabapentin, prescribed or not.

The Centers for Disease Control and Prevention (CDC) describes how combining opioids with other sedating substances raises overdose risk. A complete medication list lets the medical team plan withdrawal care and make sure naloxone is part of the safety plan. If you are worried about someone right now, and they are hard to wake, breathing slowly, or making snoring or gurgling sounds, call 911.

What Withdrawal Can Look Like in the First Week

People who have been taking high daily amounts and stop suddenly may report anxiety, agitation, restlessness, insomnia, sweating, nausea, and a rebound of the pain the medication was treating. Seizures are the most serious risk, especially for anyone with a seizure history or who is also coming off alcohol or benzodiazepines.

That last point is critical. Alcohol withdrawal and benzodiazepine withdrawal both carry a risk of seizures and can be life-threatening. Medical supervision is required. When gabapentin or pregabalin dependence overlaps with either of those, withdrawal planning needs to account for all of them at once. Families sometimes notice the first week as a person who seems “on edge” and unable to sleep, and that is a reason to keep the medical team informed, not a reason to give an extra dose from the home supply.

The National Institute on Drug Abuse (NIDA) notes that medically managed withdrawal is only the first stage of treatment and is rarely enough on its own to sustain recovery. The taper is the start, not the treatment.

What to Tell Admissions: A Checklist to Fill In Today

Before you call, take five minutes and write down the following. If you are calling for a family member, gather what you can and leave the rest blank. Admissions can work with partial information, but not with information nobody mentions.

  1. Exact product and strength: Gabapentin or pregabalin, the milligram strength printed on the bottle, and whether it is capsules, tablets, or liquid.
  2. Prescribed amount versus actual amount: What the label says per day, and what is actually being taken per day. Count what is left in the bottle against the fill date if you are unsure.
  3. Source: One prescriber, more than one prescriber, or obtained from someone else. This is clinical information, not a judgment.
  4. Time of the last dose: Withdrawal planning depends on it.
  5. Everything else taken alongside it: Opioids, buprenorphine or methadone, benzodiazepines, alcohol, sleep medications, or muscle relaxants.
  6. Seizure history: Any past seizure, including during a previous withdrawal.
  7. Why it was first prescribed: Nerve pain, seizures, anxiety, or sleep. The underlying condition still needs a treatment plan after the taper.

Bring the original pharmacy bottles on admission day. Our admissions team can walk you through what to bring and how prescriptions are reconciled when you call (877) 328-1968.

How Residential Treatment Handles the Taper

In a residential setting, gabapentin or pregabalin is typically reviewed by the medical team during intake. The prescriber confirms the actual daily amount, considers other substances and health conditions, and sets a taper schedule. Doses are held and dispensed by staff rather than self-administered, which removes the guesswork and the temptation to take extra on a hard night.

Because the taper usually runs alongside therapy rather than before it, people can begin residential treatment work in the first days instead of waiting for withdrawal to finish. If pain was the original reason for the prescription, the plan should include non-addictive pain strategies and a handoff to an outpatient prescriber at discharge. The Substance Abuse and Mental Health Services Administration (SAMHSA) emphasizes treating co-occurring physical and mental health conditions alongside substance use, and chronic pain is one of the most common examples.

A residential stay is not the right level of care for everyone who takes gabapentin. Someone taking it exactly as prescribed, with no other substance use, may simply need their own prescriber to manage a taper. Residential care makes sense when the medication is part of a broader pattern, when other depressants are involved, or when previous attempts to cut back on their own have not held.

Questions to Ask Before You Commit to a Program

  • Does the program have a prescriber on staff who reviews gabapentin and pregabalin at intake, rather than stopping all non-essential medications?
  • How is a taper handled when alcohol, benzodiazepines, or opioids are also involved?
  • Is naloxone included in the discharge plan for anyone with opioid use?
  • What happens to the original pain or anxiety condition after the taper ends?
  • Will my insurance cover the stay? You can start that process through our insurance verification page.

A Note From the Clinical Side

The most useful thing a person or family can do is mention gabapentin or pregabalin on the very first call, even if it seems minor. Medication that is disclosed can be tapered safely. Medication that surfaces on day three, after a withdrawal symptom nobody planned for, is harder for everyone. If you are not sure whether it matters, assume it does and say it out loud.

This article was written by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i. To talk through a specific situation confidentially, call (877) 328-1968.

This article is for educational purposes only and is not medical advice. Do not stop, reduce, or change any prescribed medication without guidance from your prescriber. Alcohol and benzodiazepine withdrawal can cause seizures and require medical supervision. If you or someone you know is in immediate danger, call 911. For a mental health or suicidal crisis, call or text 988.